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Summal'y 
The expression of Fas ligand on natural killer (NK) cells and Fas-mediated cytotoxicity by NK 
cells was investigated.  Fas ligand mRNA was expressed in freshly isolated NK cells but not in 
T  cells.  Furthermore,  the Fas ligand was detected  on the cell  surface of NK ceils by staining 
with soluble Fas molecule. We analyzed the cytolytic activity of NK cells against thymocyte 
targets from normal and Ipr mice, and found that the NK cells killed thymocytes from normal 
mice but not from lpr mice. On the other hand,  splenic T  cells did not show any cytotoxicity 
against either of the thymocyte targets. Similarly,  NK cells exhibited cytotoxicity against trans- 
fectants expressing Fas antigen but not against parental cells or transfectants expressing a mutant 
Fas antigen with deleted cytoplasmic region.  These results demonstrated that NK cells express 
Fas ligand and possess the capability of killing target cells expressing Fas antigen on their surface. 
This finding suggests that NK cells play an important  role by eliminating Fas-expressing cells 
either  constitutively or inducibly in peripheral  lymphoid organs. 
F  as  is  a  transmembrane  protein  that  transduces  apop- 
totic signals into cells (1) and is expressed on immature 
thymocytes, activated T cells, and nonlymphoid cells in liver, 
ovary, and heart,  etc.  (2,  3).  It is interesting  that  the loss 
of its expression or of its ligand results in immune disorders 
including autoantibody production and abnormal T cell ac- 
cumulation in lymphoid organs as observed in llor orgld mice, 
respectively (4, 5). This indicates that the Fas and Fas ligand 
interaction  is important  for the immune  system and is in- 
volved in negative selection in lymphocyte differentiation. 
Therefore, identification of cells that express. Fas ligand and 
that  kill  cells  expressing  Fas  in  each  tissue  is  crucial  for 
darifying the function of Fas in the immune system. Recently, 
Fas ligand was found to be expressed on activated T cells or 
some T  cell lines  (6-12).  Furthermore,  we have found that 
Fas  ligand  is expressed  on  freshly isolated NKI.1 + TCR- 
o~/B + T  cells in thymus and mediates cytotoxicity against 
CD4 § CD8 §  thymocytes via Fas  (13).  However, it  is  still 
unclear whether  the expression of Fas ligand is limited  to 
the T cell population. In the present study, by analyzing highly 
purified NK cells, we found that NK cells express Fas ligand 
on the cell surface and exhibit Fas-mediated cytotoxicity against 
Fas-expressing target ceils. These findings suggest that NK 
cells may regulate the immune system through cytotoxicity 
against  Fas-expressing ceils. 
Materials  and Methods 
Mice.  MRL/Mpj-+/+  (MILL +/+)  and MRL/Mpj-lpr/lpr 
(MRL Ipr/Ipr  ) mice were obtained from the Shizuoka Laboratory 
Animal Corporation  (Hamamatsu,  Shizuoka Prefecture, Japan). 
C57BL/6J Jcl (B6) mice were obtained from the Japan Clea An- 
imal Corporation  (Tokyo, Japan). 
CellPrepamtion.  Cells  were purified as previously described (13). 
Briefly, splenocytes from 6-8-wk-old B6 mice were treated with 
magnetic beads (Advanced Magnetics, Inc., Cambridge, MA) cou- 
pled with goat anti-mouse-IgG Ab (Cappel, Organon Teknika Co., 
West Chester, PA) to remove surface Ig (sIg) § B cells. The sIg- 
splenocytes, >90%  being CD3 + cells, were used as the T  cell 
population.  To isolate NK cells, the sIg- splenocytes were mixed 
with anti-CD4 mAb (GK1.5) and anti-CD8 mAb (53.6.7) followed 
by incubation with magnetic beads coupled with goat anti-rat IgG 
Ab (Cappel) to enrich NK cells. The residual cells were then in- 
cubated with PE-anti-NKl.1 mAb and biotin-anti-CD3 mAb (Phar- 
Mingen, San Diego, CA) followed  by Tri-Color-streptavidin (Caltag 
Laboratories, San Francisco, CA). The stained cells were sorted into 
NKI.1 § CD3-  cells by FACStar  plu~|  (Becton Dickinson  & Co., 
Mountain  View, CA). The purity of the sorted cells was always 
~99%. 
Reverse Transcription (RT)-PCR.  Total cellular RNA was ex- 
tracted by the guanidinium-isothiocyanate  method.  Single strand 
cDNA was synthesized with reverse transcriptase from 0.5 gg RNA 
and was used for PCR reaction. Primer sequences were as follows: 
3-actin:  5'primer-TGGAATCCTGTGGCATCCATGAAAC  and 
3'primer-TAAAACGCAGCTCAGTAACAGTCCG;  Fas  ligand: 
.5'primer-ATGG~TGC~TCTGGT  and Yprimer-GTTTAG- 
GGGCTGGTTGTTGC. Various amounts of cDNAs were ampli- 
fied in PCR under the following conditions: 94~  for I min, 57~ 
for I min, and 72~  for 1.5 min with 20 cycles  for 3-actin or with 
24 cycles for Fas ligand. After amplification, PCR products were 
separated by electrophoresis on 1.5% agarose gel containing ethi- 
dium bromide  and visualized by UV light  illumination. 
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chimeric molecule was kindly provided by Dr. S. Nagata  (Osaka 
Bioscience Institute,  Suita,  Japan)  (5). SIg-  splenocytes were 
mixed with the Fas-lg molecule or human myeloma IgG1 control 
Ab (The Binding Site Ltd., Birmingham,  UK) followed by FITC- 
anti-human  IgG Ab (Cappel). After blocking nonspecific binding 
rites of  anti-human IgG Ab with mouse and rat Ig, ceils  were stained 
with PE-anti-NKl.1  and biotin-anti-CD3  mAb followed by Tri- 
Color-streptavidin. Stained cells  were analyzed  by FACScan  |  (Becton 
Dickinson  & Co.). 
Cytotoxic Assay.  Target thymocytes were prepared from 3-4- 
wk-old mice. Fas transfectants were prepared as described previ- 
ously (9,  11,  13). Cytotoxic assay was carried out as previously 
reported (13-15). Briefly,  target cells  were labeled  with PKH-2 green 
fluorescence dye (Zynaxis Cell Science, Inc., Malvern, PA). After 
the labeling, living ceils  were purified by lymphoseparator (Immuno- 
Biological  Laboratories, Fujioka,  Japan). The stained cells  were mixed 
with various numbers of effector cells and incubated for 12 h after 
centrifugation in a U-bottomed 96-well microplate (Falcon, Becton 
Dickinson  & Co.) in 200/zl of RPMI-1640  supplemented  with 
10% FCS, kanamycin (100 #g/ml) and 5  x  10 -s M 2-ME. After 
the culture,  the proportion  of dead cells among  PKH-2-stained 
cells was determined via FACScan  |  by staining the cultured ceils 
with propidium iodide (PI) red fluorescence dye (Sigma Chemical 
Co., St. Louis, MO). Data are presented as mean _+ SD from tripli- 
cate cultures. 
Results and Discussion 
To analyze the expression of Fas ligand transcripts on NK 
cells,  the  NKI.1 + CD3-  population,  which is thought  to 
be mouse NK cell population (16), was sorted from CD4- 
CD8-  slg-  splenocytes. The purity of the sorted NKI.1 + 
CD3-  cells was constantly >99%. However, since the prep- 
aration of sufficient numbers of cell~ with this purity for per- 
forming Northern blot analysis is very difficult, we employed 
RT-PCR to  detect Fas ligand  mRNA in NK cells.  Fig.  1 
shows the expression of Fas ligand mRNA and/3-actin mRNA 
as a control in purified NK cells and slg-  splenocytes, most 
of which are T  cells (>90%).  Whereas the expression level 
of B-actin mRNA was almost the same between T  and NK 
cells, Fas ligand mRNA was detected only in NK cells under 
our experimental conditions. Predicted patterns of restriction 
enzyme digestion proved that  the  amplified fragment  cor- 
responded to Fas ligand  (data not  shown).  The  expression 
of Fas ligand  on the cell surface of NK cells was then ana- 
lyzed by staining with the soluble Fas-Ig chimeric molecule. 
As shown in  Fig.  2,  NKI.1 §  CD3-  splenocytes were sig- 
nificantly stained by the Fas-Ig molecule, whereas NKI.1- 
CD3 § cells, as conventional spleen T  cells, were not stained. 
From these observations, it was demonstrated that NK cells 
express  Fas  ligand  on  their  cell surface. 
To investigate whether  the Fas ligand  expressed on NK 
cells is functional,  the cytotoxicity of NK cells against Fas- 
expressing cells was analyzed. Since thymocytes express Fas 
and have been used as targets for Fas-mediated cytotoxicity 
by T  cells  (6,  10,  13)  and  since  thymocytes are  known  to 
be sensitive to cytotoxicity by NK cells  (17),  we used thy- 
mocytes from normal  and Ipr mice as targets.  As shown in 
Fig. 3, NK cells showed significant cytotoxicity against thymo- 
cyte targets from MRL  +/+  mice, but only weak cytotox- 
icity against thymocytes from MILL lpr/lpr mice. On the other 
hand,  splenic T  cells did not show any cytotoxicity against 
either  of the targets.  The  sIg- CD4- CD8- CD3-  popula- 
tion, "~50-60% of which was NK cells, showed similar cy- 
totoxicity against thymocyte targets (data not shown). Fur- 
thermore,  NKI.1 mAb did not affect the cytotoxicity of the 
sIg-CD4-CD8-CD3-  population (data not shown). These 
observations exclude the possibility that the cytotoxicity of 
NK cells against thymocytes resulted from the additional ac- 
tivation of NK cells by NKI.1  mAb used for purification. 
We confirmed Fas-mediated cytotoxicity of NK cells by 
using Fas transfectants.  L5178Y (a Fc receptor-negative T lym- 
phoma line derived from DBA/2 mice) was transfected with 
either a full-length Fas cDNA or a mutated Fas cDNA lacking 
cytoplasmic domain (90 amino acids had been removed from 
the COOH-terminal end) (13). NK cells significantly killed 
Fas-transfected lymphoma cells (A-1 cells),  but not parental 
lymphoma cells  (L5175Y) or mutated-Fas  transfected cells 
(F-10) (Fig. 4). Splenic T cells did not reveal any cytotoxicity 
against these cells. In addition,  these transfectants have been 
shown to be similarly  sensitive to the cytotoxidty by aUoreac- 
tive CTL (13).  From these results, it can be concluded that 
Figure  1.  Expression  of Fas ligand mRNA 
on NK cells. The expression  of Fas ligand and 
B-actin mRNA in slg - CD4- CD8- NKI.1 + 
CD3- splenocytes  (NK cell) or slg- spleno- 
cytes (T cell) was analyzed  by RT-PCR. The 
amounts of RNA (rig) used for amplification 
are indicated. Representative  data from three 
independent experiments are shown. 
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cells. SIg- splenocytes  were stained with Fas-Ig (open 
histogram) or human mydoma  IgG1 control  Ab (hatched 
histogram) plus FITC-anti-human IgG Ab, PE-anti- 
NKI.1 mAb and biotin-anti-CD3 mAb plus Tri-Color- 
streptavidin. NKI.1 + CD3-  and  NKI.1-  CD3+ 
populations were gated (.4) and the staining pattern 
of  Fas-Ig  on each  population  is illustrated (B). Repre- 
sentative data from three independent experiments are 
shown. 
the Fas ligand expressed on NK cells is functional and mediates 
cytotoxicity against specific lymphocyte populations or tumor 
cells  expressing  Fas. 
Fas ligand was recently cloned, and it was shown that its 
expression is upregulated upon stimulation of T cells (7). On 
the other hand,  we have found that freshly isolated NKI.1 + 
TCR-ot//~ + T cells constitutively express Fas ligand and kill 
CD4 +  CD8 + thymocytes (13).  Collectively, some activated 
T  cells and NKI.1 + T  cells express Fas ligand and have the 
important function of eliminating Fas-expressing cells. In the 
present study, we found that not only these T cells but also 
freshly isolated NK ceils express functional Fas ligand  that 
induces Fas-mediated cytotoxidty. This finding indicates that 
NK cells,  similar to NKI.1 + T  cells,  seem to be important 
for the immune  system since they congenitally express Fas 
ligand  in  vivo without  additional  stimulation. 
In both lpr and gld mice, autoantibody production and ac- 
cumulation  of abnormal T  cells are observed. Therefore,  it 
is reasonable to speculate that  a major role of Fas  and Fas 
ligand interaction in vivo is to prevent the progression of au- 
toimmunity or abnormal T cell development. However, the 
mechanism of the onset of disorders observed in these mice 
is still unclear.  Considering  that Fas is expressed on imma- 
ture thymocytes or activated T  cells among lymphoid cells 
(3),  identification  of populations  that  express Fas ligand in 
thymus  and  peripheral  lymphoid  organs  is  important  for 
clarifying  the  role  of Fas  both  in  these  autoimmune  dis- 
orders  and  in  normal  immune  responses.  In  thymus,  NK 
cells and activated conventional T  cells are hardly detected, 
and NKI.1 + TCtL-c~//3 + T cells are the only population ex- 
pressing Fas ligand (13).  These observations have suggested 
that  NKI.1 +  TCR-c~//3 +  thymocytes  are  important  cells 
regulating thymocyte development. In peripheral lymphoid 
organs,  at least three populations express Fas ligand: NK cells, 
NKI.1 +  T  ceils,  and  activated  T  ceils  (memory  T  cells). 
These populations are possibly involved in regulating the im- 
mune system through cytotoxicity against Fas-expressing  cells 
in these organs.  At present,  it is unclear whether only Fas 
ligand on these effector cells is responsible for the cytotox- 
icity against Fas-expressing cells, because there seems to be 
antigen specificity,  even in Fas-mediated cytotoxicity, similar 
to  perforin-mediated  cytotoxicity (8,  9).  Therefore,  these 
different types of effector cells expressing Fas ligand, depending 
on the nature of these effector cells,  may kill different types 
of target  cells. 
Introduction of Fas into tumor cells significantly induced 
their susceptibility to the cytotoxicity of NK cells.  This re- 
sult suggests that not only perforin-mediated cytotoxicity (18) 
but also Fas-mediated cytotoxicity is involved in the NK cell 
cytotoxicity. However, the NK activity in gld mice expressing 
the mutated Fas ligand  did not differ from that  in normal 
mice when NK-sensitive YAC-1  cells were used as targets, 
which express low levels of Fas (Arase,  H., and T. Saito,  un- 
published observation). In contrast, EL-4 cells also expressing 
Fas (6) are known to be an NK-resistant cell line.  From these 
observations,  the  susceptibility of target  cells  to  NK cells 
NK cell  T cell  NK cell  T cell 
._  .~  ￿9  L51V  ￿9  L5178Y 
,  1~  20  4P  ,0  ;  0  .....  0. 
-  ,  -  .....  5:1  16:1  50:1  5:1  16:1  50:1 
1.8:1  5.0:1  18:1  50:1  1.8:1  5.0:1  18:1  50:1  E/Tratio  E/Tratio 
Err ratio  Err ratio 
Figure  3.  Cytotoxicity  of NK cells against thymocyte  targets. Cyto- 
toxicity of slg - CD4 - CD8 - NKI.  1  +  CD3 -  splenocytes  (NK cell) or slg - 
splenocytes  (Tcell) against thymocytes  from MRL +/+  (open circles) or 
MRL Ipr/Ipr (closed circles) mice was analyzed. Representative  data from 
three independent experiments are shown. 
Fig,,re  4.  Cytotoxicity  of NK cells  against Fas-transfectants. Cytotox- 
icity of slg-CD4-CD8-NKI.I*CD3-  splenocytes  (NK cell) or slg- 
splenocytes  (T cell) against transfectants expressing Fas (A-l, closed  circles), 
transfectants expressing  mutated Fas (tzlO, closed  squares) or parental cells 
(L5178Y,, closed  triangles). Representative  data from three independent ex- 
periments are shown. 
1237  Arase et al.  Brief  Definitive Report cannot be merely explained by the expression of Fas. Involve- 
ment of Fas in the cytotoxicity by NK cells might be deter- 
mined by the characteristics  of the target cells. For example, 
bcl-2 expression  has been reported to antagonize signals for 
apoptosis by Fas (19). On the other hand, class I expression 
on target cells is correlated to their susceptibility to NK cells 
(20, 21). Therefore, the expression of these molecules as well 
as Fas on target cells may contribute to the involvement of 
Fas in the cytotoxicity of NK cells. Further analysis will elu- 
cidate the specificity and function of Fas-mediated cytotox- 
icity by NK cells. 
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